Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [41] Prostate Cancer Screening Shared Decision-Making for Screening and Treatment
    Blackwelder, Russ
    Chessman, Alexander
    PRIMARY CARE, 2019, 46 (01): : 149 - +
  • [42] Treatment Perceptions and Decision-Making Among Physicians Treating Essential Tremor
    Gerbasi, Margaret
    Elble, Rodger
    Jones, Eddie
    Gillespie, Alexander
    Jarvis, John
    Chertavian, Elizabeth
    Smith, Zachary
    Bankole, Kemi
    Shankar, Sriram
    Shih, Ludy
    NEUROLOGY, 2023, 100 (17)
  • [43] The impact of patient decision aids on the shared decision-making in cancer treatment
    Lin, Wan-Shiuan
    Yang, Yuan-Hao
    ANNALS OF ONCOLOGY, 2022, 33 : S490 - S490
  • [44] The physician-patient encounter: The physician as a perfect agent for the patient versus the informed treatment decision-making model
    Gafni, A
    Charles, C
    Whelan, T
    SOCIAL SCIENCE & MEDICINE, 1998, 47 (03) : 347 - 354
  • [45] Patient and physician perceptions: Importance and documentation of patient priorities in treatment planning and decision-making.
    Miller-Sonet, Ellen
    Rocque, Gabrielle Betty
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [46] Patient involvement in medical decision-making and pain among elders: physician or patient-driven?
    Tyrone F Borders
    Ke Tom Xu
    James Heavner
    Gina Kruse
    BMC Health Services Research, 5
  • [47] Patient involvement in medical decision-making and pain among elders: Physician or patient-driven?
    Borders, TF
    Xu, KT
    Heavner, J
    Kruse, G
    BMC HEALTH SERVICES RESEARCH, 2005, 5 (1)
  • [48] A prospective evaluation of patient perspectives and financial considerations during prostate cancer treatment decision-making
    Rai, Karnvir S.
    Mann, Uday
    Harasemiw, Oksana
    Tangri, Navdeep
    Eng, Amanda
    Patel, Premal
    Nayak, Jasmir G.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2023, 17 (09): : E244 - E251
  • [49] No time for reflection: Patient experiences with treatment-related decision-making in advanced prostate cancer
    Netsey-Afedo, Mette Margrethe Lowe
    Ammentorp, Jette
    Osther, Palle Jorn Sloth
    Birkelund, Regner
    SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2020, 34 (04) : 880 - 888
  • [50] Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma
    Orr, Lisa Dwyer
    Lin, Dee
    Wu, Bingcao
    Leblanc, Thomas W.
    Faiman, Beth
    Ahlstrom, Jenny
    Yung, Margaret
    Deering, Kathleen L.
    Kulbokas, Victoria
    Feldman, Joshua L.
    Kline, Erika
    Biran, Noa
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 2147 - 2158